NCT03714178View on ClinicalTrials.gov

A Safety and Feasibility Study of the FARAPULSE Endocardial Ablation System to Treat Paroxysmal Atrial Fibrillation

NACompletedINTERVENTIONAL
Enrollment

71

Participants

Timeline

Start Date

October 20, 2018

Primary Completion Date

December 21, 2020

Study Completion Date

December 21, 2020

Conditions
Paroxysmal Atrial Fibrillation
Interventions
DEVICE

FARAPULSE Endocardial Ablation System

Endocardial ablation using the FARAPULSE Endocardial Ablation System.

Trial Locations (2)

Unknown

Nemocnice Na Homolce, Prague

CHU Bordeaux, Pessac

Sponsors
All Listed Sponsors
lead

Boston Scientific Corporation

INDUSTRY